Chen et al. treated caerulein-induced AP rats with ligustrazine, observing that it reduced serum levels of inflammatory factors, upregulated p53 and cleaved caspase-3 expression, and effectively alleviated AP symptoms. The gene discussed is CASP3; the disease is alkaline phosphatase measurement.